Google
CRBP — CORBUS PHARMACEUTICALS HOLDING (Healthcare >> Biotechnology)
CRBP FAQ
What is CRBP's ROE?
CORBUS PHARMACEUTICALS HOLDING reports a Return on Equity (ROE) of -66.90%.
What is CRBP's dividend yield?
CORBUS PHARMACEUTICALS HOLDING offers a dividend yield of 0.00%.
What is CRBP's Deepscope Quality Score?
Deepscope rates CRBP's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CRBP?
Deepscope's AI Timing Score for CRBP is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CRBP belong to?
CORBUS PHARMACEUTICALS HOLDING is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 7.56
Price
-0.45
(-5.62%)
Day Change
|
|
|---|
CRBP, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 76 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 7.56 |
| PBV / Sector |
1.11 / 4.63
GREAT
|
| Earning Per Share | -4.56 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
6.14 M
|
| Average 1W Daily Value |
4.76 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:21 |
| Symbol | CRBP |
| Name | CORBUS PHARMACEUTICALS HOLDING |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 18.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 140.07 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 River Ridge Drive, Norwood, MA, United States, 02062
Phone: 617 963 0100
Website: https://www.corbuspharma.com
Sector: Healthcare >> Biotechnology
Description: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
